{
  "issues": [
    "Renal tool flagged a missing BMI and missing lab timestamps, indicating incomplete data that could affect risk calculations.",
    "Renal tool confidence is low (0.52), suggesting the risk assessment may be unreliable without complete data.",
    "Agent 2 recommends a standard CT Pulmonary Angiography (CTA) with 100‑150 mL iodinated contrast, which exceeds typical low‑volume recommendations for eGFR <30 mL/min/1.73 m².",
    "Hyper‑kalemia (K⁺ = 5.8 mmol/L) is not addressed; severe hyper‑kalemia should be corrected before contrast administration to avoid cardiac arrhythmias.",
    "Patient is hypotensive (MAP = 57 mmHg) and may not tolerate rapid contrast injection or the additional fluid load required for aggressive hydration.",
    "Agent 2 does not prioritize alternative, contrast‑sparing imaging modalities (e.g., ventilation‑perfusion scan, bedside transthoracic echocardiography) that could answer the clinical question without renal risk.",
    "The protocol’s “contrast‑to‑eGFR ratio <1.1 g/(mL/min)” is incorrectly expressed and does not provide a clear, actionable limit on contrast volume for this patient.",
    "No specific pre‑procedural renal protective measures (e.g., isotonic saline hydration protocol, sodium bicarbonate, temporary discontinuation of nephrotoxic drugs) are outlined."
  ],
  "recommendations": [
    "1. Verify and supplement missing data (BMI, exact timestamps of labs) before finalizing the risk assessment.",
    "2. Treat hyper‑kalemia urgently (e.g., insulin + dextrose, calcium gluconate, beta‑agonists) and re‑check serum K⁺ before any contrast exposure.",
    "3. Stabilize hemodynamics: raise MAP >65 mmHg with cautious fluid resuscitation or vasopressors prior to contrast administration.",
    "4. If CTA is deemed absolutely necessary, limit contrast volume to the lowest feasible amount (e.g., 40‑60 mL of low‑osmolar or iso‑osmolar contrast) and use a high‑flow injector with a reduced injection rate (3‑4 mL/s) to minimize renal load.",
    "5. Implement a renal protection protocol: 1 mL/kg/h isotonic saline (e.g., 0.9% NaCl) for 12 h pre‑ and 12 h post‑contrast; consider adding sodium bicarbonate infusion if institutionally supported.",
    "6. Consider alternative, contrast‑free imaging first:",
    "   • Ventilation‑perfusion (V/Q) scan if the patient can undergo nuclear imaging and the pre‑test probability of PE is moderate‑high.",
    "   • Bedside transthoracic echocardiography to assess right‑ventricular strain as a rapid surrogate for PE.",
    "   • If chest CTA is unavoidable, document shared decision‑making and obtain informed consent detailing CIN risk.",
    "7. Update the protocol documentation to replace the ambiguous “contrast‑to‑eGFR ratio <1.1 g/(mL/min)” with a clear statement such as “use ≤ 0.5 × eGFR (mL) contrast volume; for eGFR = 22 mL/min, limit contrast ≤ 11 mL, but a minimum of 30‑40 mL is often required for diagnostic quality – thus balance diagnostic need vs. renal risk and consider low‑dose techniques or dual‑energy CT to reduce volume.”",
    "8. After the study, repeat renal labs (creatinine, BUN, electrolytes) within 48 h to detect any contrast‑induced nephropathy early.",
    "9. Document all renal protective steps in the EMR and ensure radiology technologists are aware of the patient’s CKD stage and hyper‑kalemia status."
  ],
  "confidence": 0.87,
  "agent2_confidence": 0.55,
  "timestamp": "2025-08-26T10:00:49.680333Z",
  "tool_outputs": {
    "renal": {
      "tool_id": "renal_tool_v2",
      "checks": [
        {
          "id": "egfr_ckd_epi",
          "units": "ml/min/1.73m2",
          "timestamp": "2025-08-26T10:00:35.253114Z",
          "priority": "critical",
          "value": 22.0,
          "status": "fail",
          "reason": "High renal risk; contrast caution."
        },
        {
          "id": "creatinine_mg_dl",
          "units": "mg/dL",
          "timestamp": "2025-08-26T10:00:35.253125Z",
          "priority": "critical",
          "value": 3.2,
          "status": "fail",
          "reason": "Creatinine significantly elevated."
        },
        {
          "id": "bun_creatinine_ratio",
          "timestamp": "2025-08-26T10:00:35.253130Z",
          "priority": "important",
          "value": 20.3,
          "status": "warning",
          "reason": "BUN/Cr ratio suggests prerenal azotemia."
        },
        {
          "id": "potassium_mmol_l",
          "units": "mEq/L",
          "timestamp": "2025-08-26T10:00:35.253139Z",
          "priority": "important",
          "value": 5.8,
          "status": "fail",
          "reason": "Critical hyperkalemia."
        }
      ],
      "summary": {
        "overall": "fail",
        "reasons": [
          "High renal risk; contrast caution.",
          "Creatinine significantly elevated.",
          "BUN/Cr ratio suggests prerenal azotemia.",
          "Critical hyperkalemia.",
          "Missing BMI or creatinine.",
          "No lab timestamps provided."
        ],
        "confidence": 0.52
      },
      "metadata": {
        "version": "2.0.0",
        "run_ts": "2025-08-26T10:00:35.253164Z"
      }
    }
  },
  "llm_raw": "{\n  \"issues\": [\n    \"Renal tool flagged a missing BMI and missing lab timestamps, indicating incomplete data that could affect risk calculations.\",\n    \"Renal tool confidence is low (0.52), suggesting the risk assessment may be unreliable without complete data.\",\n    \"Agent 2 recommends a standard CT Pulmonary Angiography (CTA) with 100‑150 mL iodinated contrast, which exceeds typical low‑volume recommendations for eGFR <30 mL/min/1.73 m².\",\n    \"Hyper‑kalemia (K⁺ = 5.8 mmol/L) is not addressed; severe hyper‑kalemia should be corrected before contrast administration to avoid cardiac arrhythmias.\",\n    \"Patient is hypotensive (MAP = 57 mmHg) and may not tolerate rapid contrast injection or the additional fluid load required for aggressive hydration.\",\n    \"Agent 2 does not prioritize alternative, contrast‑sparing imaging modalities (e.g., ventilation‑perfusion scan, bedside transthoracic echocardiography) that could answer the clinical question without renal risk.\",\n    \"The protocol’s “contrast‑to‑eGFR ratio <1.1 g/(mL/min)” is incorrectly expressed and does not provide a clear, actionable limit on contrast volume for this patient.\",\n    \"No specific pre‑procedural renal protective measures (e.g., isotonic saline hydration protocol, sodium bicarbonate, temporary discontinuation of nephrotoxic drugs) are outlined.\"\n  ],\n  \"recommendations\": [\n    \"1. Verify and supplement missing data (BMI, exact timestamps of labs) before finalizing the risk assessment.\",\n    \"2. Treat hyper‑kalemia urgently (e.g., insulin + dextrose, calcium gluconate, beta‑agonists) and re‑check serum K⁺ before any contrast exposure.\",\n    \"3. Stabilize hemodynamics: raise MAP >65 mmHg with cautious fluid resuscitation or vasopressors prior to contrast administration.\",\n    \"4. If CTA is deemed absolutely necessary, limit contrast volume to the lowest feasible amount (e.g., 40‑60 mL of low‑osmolar or iso‑osmolar contrast) and use a high‑flow injector with a reduced injection rate (3‑4 mL/s) to minimize renal load.\",\n    \"5. Implement a renal protection protocol: 1 mL/kg/h isotonic saline (e.g., 0.9% NaCl) for 12 h pre‑ and 12 h post‑contrast; consider adding sodium bicarbonate infusion if institutionally supported.\",\n    \"6. Consider alternative, contrast‑free imaging first:\",\n    \"   • Ventilation‑perfusion (V/Q) scan if the patient can undergo nuclear imaging and the pre‑test probability of PE is moderate‑high.\",\n    \"   • Bedside transthoracic echocardiography to assess right‑ventricular strain as a rapid surrogate for PE.\",\n    \"   • If chest CTA is unavoidable, document shared decision‑making and obtain informed consent detailing CIN risk.\",\n    \"7. Update the protocol documentation to replace the ambiguous “contrast‑to‑eGFR ratio <1.1 g/(mL/min)” with a clear statement such as “use ≤ 0.5 × eGFR (mL) contrast volume; for eGFR = 22 mL/min, limit contrast ≤ 11 mL, but a minimum of 30‑40 mL is often required for diagnostic quality – thus balance diagnostic need vs. renal risk and consider low‑dose techniques or dual‑energy CT to reduce volume.”\",\n    \"8. After the study, repeat renal labs (creatinine, BUN, electrolytes) within 48 h to detect any contrast‑induced nephropathy early.\",\n    \"9. Document all renal protective steps in the EMR and ensure radiology technologists are aware of the patient’s CKD stage and hyper‑kalemia status.\"\n  ],\n  \"confidence\": 0.87\n}",
  "hallucination_analysis": {
    "statement_assessments": [
      {
        "text": "Renal tool flagged a missing BMI and missing lab timestamps, indicating incomplete data that could affect risk calculations.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Renal tool confidence is low (0.52), suggesting the risk assessment may be unreliable without complete data.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Agent 2 recommends a standard CT Pulmonary Angiography (CTA) with 100‑150 mL iodinated contrast, which exceeds typical low‑volume recommendations for eGFR <30 mL/min/1.73 m².",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Hyper‑kalemia (K⁺ = 5.8 mmol/L) is not addressed; severe hyper‑kalemia should be corrected before contrast administration to avoid cardiac arrhythmias.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact '5.8'"
      },
      {
        "text": "Patient is hypotensive (MAP = 57 mmHg) and may not tolerate rapid contrast injection or the additional fluid load required for aggressive hydration.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Agent 2 does not prioritize alternative, contrast‑sparing imaging modalities (e.g., ventilation‑perfusion scan, bedside transthoracic echocardiography) that could answer the clinical question without renal risk.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "The protocol’s “contrast‑to‑eGFR ratio <1.1 g/(mL/min)” is incorrectly expressed and does not provide a clear, actionable limit on contrast volume for this patient.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "No specific pre‑procedural renal protective measures (e.g., isotonic saline hydration protocol, sodium bicarbonate, temporary discontinuation of nephrotoxic drugs) are outlined.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "1. Verify and supplement missing data (BMI, exact timestamps of labs) before finalizing the risk assessment.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "2. Treat hyper‑kalemia urgently (e.g., insulin + dextrose, calcium gluconate, beta‑agonists) and re‑check serum K⁺ before any contrast exposure.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "3. Stabilize hemodynamics: raise MAP >65 mmHg with cautious fluid resuscitation or vasopressors prior to contrast administration.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "4. If CTA is deemed absolutely necessary, limit contrast volume to the lowest feasible amount (e.g., 40‑60 mL of low‑osmolar or iso‑osmolar contrast) and use a high‑flow injector with a reduced injection rate (3‑4 mL/s) to minimize renal load.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "5. Implement a renal protection protocol: 1 mL/kg/h isotonic saline (e.g., 0.9% NaCl) for 12 h pre‑ and 12 h post‑contrast; consider adding sodium bicarbonate infusion if institutionally supported.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "6. Consider alternative, contrast‑free imaging first:",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "   • Ventilation‑perfusion (V/Q) scan if the patient can undergo nuclear imaging and the pre‑test probability of PE is moderate‑high.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "   • Bedside transthoracic echocardiography to assess right‑ventricular strain as a rapid surrogate for PE.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "   • If chest CTA is unavoidable, document shared decision‑making and obtain informed consent detailing CIN risk.",
        "type": "recommendation",
        "classification": "domain_safe",
        "rationale": "matches safe-whitelist 'obtain informed consent'"
      },
      {
        "text": "7. Update the protocol documentation to replace the ambiguous “contrast‑to‑eGFR ratio <1.1 g/(mL/min)” with a clear statement such as “use ≤ 0.5 × eGFR (mL) contrast volume; for eGFR = 22 mL/min, limit contrast ≤ 11 mL, but a minimum of 30‑40 mL is often required for diagnostic quality – thus balance diagnostic need vs. renal risk and consider low‑dose techniques or dual‑energy CT to reduce volume.”",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "8. After the study, repeat renal labs (creatinine, BUN, electrolytes) within 48 h to detect any contrast‑induced nephropathy early.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "9. Document all renal protective steps in the EMR and ensure radiology technologists are aware of the patient’s CKD stage and hyper‑kalemia status.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      }
    ],
    "counts": {
      "supported": 19,
      "inferred": 0,
      "domain_safe": 1,
      "unverified": 0,
      "contradicted": 0
    },
    "hallucination_score": 0.0,
    "recommendation": {
      "force_revision": false,
      "confidence_reduction": 0.0
    },
    "knowledge_base_summary": {
      "numbers": {
        "subject_id": 30045678.0,
        "hadm_id": 45678912.0,
        "stay_id": 55661234.0,
        "age": 72.0,
        "hospital_expire_flag": 0.0,
        "los_hospital_days": 5.1,
        "los_icu_days": 4.6,
        "creatinine_mg_dl": 3.2,
        "bun_mg_dl": 65.0,
        "glucose_mg_dl": 180.0,
        "hemoglobin_g_dl": 9.5,
        "hematocrit_pct": 28.2,
        "platelet_count": 198.0,
        "wbc_count": 14.7,
        "sodium_meq_l": 134.0,
        "potassium_mmol_l": 5.8,
        "chloride_meq_l": 102.0,
        "bicarbonate_meq_l": 18.0,
        "egfr_ckd_epi": 22.0,
        "ckd_stage": 4.0,
        "bun_creatinine_ratio": 20.3,
        "heart_rate_bpm": 102.0,
        "systolic_bp_mmhg": 86.0,
        "diastolic_bp_mmhg": 42.0,
        "map_mmhg": 57.0,
        "pulse_pressure_mmhg": 44.0,
        "temperature_f": 100.2,
        "spo2_pct": 92.0,
        "respiratory_rate": 26.0,
        "data_completeness_pct": 0.91
      },
      "raw_strings_sample": [
        "white",
        "14.7",
        "5.8",
        "emergency",
        "22.0",
        "134.0",
        "high renal risk; contrast caution.",
        "creatinine_mg_dl",
        "bun_creatinine_ratio",
        "4.6"
      ]
    }
  },
  "feedback": {
    "issues": [
      "Renal tool flagged a missing BMI and missing lab timestamps, indicating incomplete data that could affect risk calculations.",
      "Renal tool confidence is low (0.52), suggesting the risk assessment may be unreliable without complete data.",
      "Agent 2 recommends a standard CT Pulmonary Angiography (CTA) with 100‑150 mL iodinated contrast, which exceeds typical low‑volume recommendations for eGFR <30 mL/min/1.73 m².",
      "Hyper‑kalemia (K⁺ = 5.8 mmol/L) is not addressed; severe hyper‑kalemia should be corrected before contrast administration to avoid cardiac arrhythmias.",
      "Patient is hypotensive (MAP = 57 mmHg) and may not tolerate rapid contrast injection or the additional fluid load required for aggressive hydration.",
      "Agent 2 does not prioritize alternative, contrast‑sparing imaging modalities (e.g., ventilation‑perfusion scan, bedside transthoracic echocardiography) that could answer the clinical question without renal risk.",
      "The protocol’s “contrast‑to‑eGFR ratio <1.1 g/(mL/min)” is incorrectly expressed and does not provide a clear, actionable limit on contrast volume for this patient.",
      "No specific pre‑procedural renal protective measures (e.g., isotonic saline hydration protocol, sodium bicarbonate, temporary discontinuation of nephrotoxic drugs) are outlined."
    ],
    "recommendations": [
      "1. Verify and supplement missing data (BMI, exact timestamps of labs) before finalizing the risk assessment.",
      "2. Treat hyper‑kalemia urgently (e.g., insulin + dextrose, calcium gluconate, beta‑agonists) and re‑check serum K⁺ before any contrast exposure.",
      "3. Stabilize hemodynamics: raise MAP >65 mmHg with cautious fluid resuscitation or vasopressors prior to contrast administration.",
      "4. If CTA is deemed absolutely necessary, limit contrast volume to the lowest feasible amount (e.g., 40‑60 mL of low‑osmolar or iso‑osmolar contrast) and use a high‑flow injector with a reduced injection rate (3‑4 mL/s) to minimize renal load.",
      "5. Implement a renal protection protocol: 1 mL/kg/h isotonic saline (e.g., 0.9% NaCl) for 12 h pre‑ and 12 h post‑contrast; consider adding sodium bicarbonate infusion if institutionally supported.",
      "6. Consider alternative, contrast‑free imaging first:",
      "   • Ventilation‑perfusion (V/Q) scan if the patient can undergo nuclear imaging and the pre‑test probability of PE is moderate‑high.",
      "   • Bedside transthoracic echocardiography to assess right‑ventricular strain as a rapid surrogate for PE.",
      "   • If chest CTA is unavoidable, document shared decision‑making and obtain informed consent detailing CIN risk.",
      "7. Update the protocol documentation to replace the ambiguous “contrast‑to‑eGFR ratio <1.1 g/(mL/min)” with a clear statement such as “use ≤ 0.5 × eGFR (mL) contrast volume; for eGFR = 22 mL/min, limit contrast ≤ 11 mL, but a minimum of 30‑40 mL is often required for diagnostic quality – thus balance diagnostic need vs. renal risk and consider low‑dose techniques or dual‑energy CT to reduce volume.”",
      "8. After the study, repeat renal labs (creatinine, BUN, electrolytes) within 48 h to detect any contrast‑induced nephropathy early.",
      "9. Document all renal protective steps in the EMR and ensure radiology technologists are aware of the patient’s CKD stage and hyper‑kalemia status."
    ],
    "confidence": 0.87
  }
}